Top 10 Traded US Stocks on POEMS in November 2020 December 11, 2020

Top 10 Traded US Stocks on POEMS in November 2020


  • All three US major indices hit their all-time highs in late November, before taking a breather as markets consolidated.
  • Electronic vehicle (EV) makers continued to dominate as investors bet on their future. .
  • Finally, some positive news on the vaccine front from Pfizer and Moderna, which announced better-than-expected drug efficacies.

Here are November’s top 10 traded US stocks on Phillip’s Online Electronic Mart System (POEMS), based on gross market value traded.

All three US major indices – Dow Jones, S&P 500 and Nasdaq Composite – made their new all-time highs in November. The Dow closed above 30,000 points for the first time, at 30,046.24 on 24 November 2020. S&P 500 traded at its 3,600 range while Nasdaq traded above 12,000.

Markets began early November fixated on US elections and Ant’s IPO. Ant’s IPO was, unfortunately, called off while the transition of power in the US was stonewalled by a defiant Trump, who refused to concede election loss. In a surprising turn in mid-month, markets became buoyed by news of COVID-19 vaccines’ Phase 3 results. Both Pfizer and Moderna said their vaccines’ effectiveness was above 90%. This hit tech stocks in general as investors rotated out of defensive and stay-at-home stocks to cyclical counters that may benefit from industry re-opening.

Starting from the 10th position:

10th: Apple Inc. (NASDAQ: AAPL)

Top 10 Traded US Stocks on POEMS in November 2020

Apple came in at the last spot in November. For the most part of the month, it tracked its performance in October, flip-flopping between US$110 and US$120.

During its “One More Thing” event on 10 November, Apple rolled out its first in-house chip, M1. This has been built into its latest laptops and desktops. With this, Apple will officially shift away from Intel chips for all its products. Apple claims that its new MacBook Air, MacBook Pro and Mac Mini have better performance and battery lives with its M1 chips.[1]

9th: Moderna Inc. (NASDAQ: MRNA)

Besides making a comeback to our top traded list, Moderna had one of its best months in November. Its share price skyrocketed from below US$70 all the way above US$150, chalking up more than a 100% gain in the month.

On 16 November, Moderna said that its preliminary Phase 3 trial data showed more than 94% efficacy, one week after Pfizer announced its results.[2] The positive news from the two major vaccine players reignited optimism in the market. On 30 November, Moderna announced final results of its trial, which confirmed a 94% efficacy. Moderna filed for emergency-use authorisation of its vaccine, on the heels of Pfizer’s filing on 20 November.[3] Once the FDA grants approval, distribution could start as early as mid-December 2020.

8th: Li Auto Inc. (NASDAQ: LI)

Top 10 Traded US Stocks on POEMS in November 2020

Chinese EV maker, Li Auto, made its first appearance on our list on the coattails of the red-hot EV industry. Almost all EV stocks enjoyed similar rallies in November. Li Auto’s share price doubled from US$22 to a high of US$47.70 in the first three weeks, before dipping back to US$36 in the last week of November.

Li Auto announced better-than-expected earnings on 13 November, beating analysts’ estimations with revenue of RMB2.5bn. Although the jump in revenue did not narrow its loss, its share price gained 25% in pre-market/post-announcement trading on the back of bullish sales guidance.[4] Towards the end of November, its share price came under pressure from profit-taking after its recent run.

7th: Palantir Technologies Inc. (NASDAQ: PLTR)

Top 10 Traded US Stocks on POEMS in November 2020

Despite its short listing history of two months, Palantir Technologies has been in the limelight of investors. It debuted on 30 September 2020 at US$10 per share and traded at US$9-10 throughout October. After reporting 52% revenue growth in its first earnings announcement since going public, its share price made its way right up to US$33.50. While revenue beat estimates, bottom-line loss also widened to US$0.94 per share from US$0.24 the previous year. A week after its earnings announcement, Soros Fund Management, the fund founded by George Soros, disclosed plans to offload its stake in Palantir. It claimed that the business practices of Palantir are not in line with the fund’s requirements.[5] Still, Palantir’s share price marched above US$30.

6th: Zoom Video Communication (NASDAQ: ZM)

Top 10 Traded US Stocks on POEMS in November 2020

Zoom further slipped one spot from its 5th position in October as investors pulled funds out of stocks that had benefitted from COVID-19 lockdowns. This was on the back of a raft of positive vaccine news. Zoom’s share price fell to US$370 before it recouped losses to trade above US$450.

As Phase 3 drug results were announced, Zoom and other “stay-at-home” stocks got abandoned by investors who rotated out to traditional industries. Although Zoom posted stunning sales growth of more than 350% for the second consecutive quarter, its share price gave up 5% in post-market trading after results announcement on 30 November.[6]

5th: Xpeng Inc. (NYSE: XPEV)

Top 10 Traded US Stocks on POEMS in November 2020

A newcomer to the list, this Chinese EV company is no stranger to EV investors. Together with its Chinese EV competitor, Nio, its share price skyrocketed in November to a 52-week high of US$74 on 24 November.

Backed by breakneck expansion, Xpeng delievred 8,578 vehicles in the latest quarter. This was a leap of 266% YoY and 166% QoQ[7]. Analysts maintained their ‘buy’ ratings on the company with the prediction that declining battery costs would expand its profit margins . The company’s Zhaoqing factory, with an annual production capacity of 250,000 vehicles, is also set to be ready in December[8]. This will help it roll out vehicles to meet demand and sustain growth.

Xpeng’s share price gained 39% in November alone, making it one of the best performers in the month.

4th: Square Inc. (NYSE: SQ)

Top 10 Traded US Stocks on POEMS in November 2020

Square Inc. came in fourth in our November list of top 10 traded stocks. The company’s share price surged for the entire month to break the US$200 level, attaining a 52-week high of US$215 on 27 November.

Riding its hugely popular CashApp peer-to-peer payment service, Square crushed analysts’ estimates with a US$0.34 EPS vs. consensus of US$0.16. Revenue was US$3.03bn, a 140% increase. The company’s share price added close to 14% following its earnings beat.[9]

Square joined other fintechs’ move into the crypto market two years ago. Its clientele reportedly accounted for 40% of all new bitcoins traded in the market in the recent two years. PayPal’s recent entry into the crypto space has fuelled demand for bitcoins.[10]

3rd: Alibaba Group Holding Ltd (NYSE: BABA)

Top 10 Traded US Stocks on POEMS in November 2020

Alibaba shot up from the 10th position in October to the top 3 in November.

This Chinese tech giant’s share price had declined steadily from its near 52-week high of US$317 on 27 October to around US$250 on 18 November, a level not seen since early August.

It started November on a rough note, as it rode a spate of bad news such as the abrupt suspension of the highly-anticipated IPO of its fintech arm, Ant Group. This IPO was supposed to have been the largest in history. Upended by increased antitrust scrutiny of online platforms and China’s crackdown on digital banking practices, investors became concerned about the regulatory impact on the future of the Alibaba Group. Hence, even though the company delivered blowout Singles Day sales and better-than-expected quarterly EPS of US$2.65 vs. estimates of US$2.12, its share price declined 9%.[11]

Towards the end of November, the coast cleared for Alibaba, which steadily made its way back from its month-low of US$255. Its recent weakness may have coaxed some investors into picking up the stock more affordably as against its 52-week high following the hype of Ant’s IPO.

2nd: Tesla Inc. (NASDAQ: TSLA)

Top 10 Traded US Stocks on POEMS in November 2020

For the first time in five months, market darling Tesla was dethroned from its top spot. After muted movements, Tesla briefly flirted around US$400 before shooting up more than 10% following news of its inclusion in the S&P 500. Its share price has never looked back since. It broke US$600 on 30 November, before closing at US$567.60.

Its inclusion in the S&P 500 provided vindication after an earlier snub by the S&P in September. With its inclusion, many index-tracking ETFs will need to rebalance their portfolios to reflect its addition. This created another round of buying frenzy. The stock was given another boost by Joe Biden’s presidential win as he promises to champion a green environment. This will benefit companies in the EV space.

1st: Nio Inc. (NYSE: NIO)

Top 10 Traded US Stocks on POEMS in November 2020

The ‘Tesla of China’ has finally unseated the real McCoy (TSLA.US)! It topped the list in November, after breaking a 52-week high of US$57.20 on 24 November.

On 2 November, the company announced it delivered a new monthly record of 5,055 cars in October. It was the first and only premium Chinese car maker to deliver over 5,000 vehicles in a month[12]. This represented 100.1% YoY growth and marked its eighth consecutive month of YoY growth. Its share price added 14% after the news.

Quarterly reports released on 18 November showed a narrower quarterly loss than expected, of -12 cents per share vs. analysts’ estimate of -20 cents. Gross margins, however, were 12.9% vs. analysts’ estimate of 14.9% [13]. Its share price captured this, retreating 8.8% in intraday trading. But that did not stop investors from piling back to the stock soon after.

Investors seem to be expecting that Nio will continue to benefit from the trend of cleaner energy adoption. Whether the company’s future sales and production can sustain its parabolic share-price movements, only time will tell.


About the author

Allen Tan & Lee Yong Heng
Senior Dealer & Dealer

Allen graduated from Nanyang Technological University with a Bachelor’s Degree, majoring in Economics with a minor in Business. He joined Phillip Securities in 2016 as an Equity Dealer in the Global Markets Team. He specialises in the US and Canada market and also supports the UK and Europe market.

Yong Heng joined Phillip Securities in June 2020 this year as an Equity Dealer in the Global Markets Team. He specializes in the US and Canada markets assisting clients and also supports the UK and Europe markets. Yong Heng graduated with First Class Honours from Singapore Institute of Management, University of London (SIM-GE) in 2015 with a Bachelor’s Degree in Economics & Finance. He also completed his CFA studies last year.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066